<DOC>
	<DOCNO>NCT01082445</DOCNO>
	<brief_summary>The purpose study determine whether N-acetylcysteine effective treatment prevention foot ulcer diabetic patient .</brief_summary>
	<brief_title>Effects N-acetylcysteine Diabetic Foot Oxygenation</brief_title>
	<detailed_description />
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Age 45 70 year . Type 1 2 diabetes mellitus foot ulcer ( grade 0 stage C accord Texas University Classification ) . Written informed consent . Nacetylcysteine assumption 6 month previous study . Hypersensibility acetylcysteine . Neoplasms , severe systemic , hepatic , pulmonary , cardiovascular renal disease . Psychiatric disease drug abuse problem .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage C</keyword>
	<keyword>grade 0 ( Texas University )</keyword>
</DOC>